GaryStevenHorwithMD

PubMed

• 5 citations
  Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) elicits high and sustained antibody responses in healthy adults
  Oshansky Cm, King J, Lu D, James Zhou, Pavetto C, Horwith G, Biscardi K, Nguyen B, Treanor Jj, Chen Lm, Jepson B, Rick A Bright, Johnson Ra, Cioce, Ruben O. Donis> ;NPJ Vaccines. 2021 Mar 19
• 6 citations
  Evaluation of BioThrax® and AV7909 anthrax vaccines in adults 66 years of age or older.
  Daniel N. Wolfe, Eric M. Espeland, Yonghong Gao, Di Lu, Gretta Blatner, Kathryn Amass, Gary Horwith, Xiaomi M. Tong, Robert J. Hopkins, Gloria David, Brett Jepson, Jam...> ;Vaccine. 2020 Oct 28
• 58 citations
  Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients
  Norbert Heinrich, Rodney Dawson, Jeannine Du Bois, Kim Narunsky, Gary Horwith, Andrew J. Phipps, Carol A. Nacy, Rob E. Aarnoutse, Martin J. Boeree, Stephen H. Gillespi...> ;The Journal of Antimicrobial Chemotherapy. 2015 May 1
• 33 citations
  The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: results of a randomized, placebo-controlled phase 1/2 trial.
  E J Wagena, Arjen de Vos, Gary Horwith, Constant P. van Schayck> ;Nicotine & Tobacco Research. 2008 Jan 1
• 36 citations
  Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced e...
  Rolland C. Dickson, Norah A. Terrault, Michael B. Ishitani, K. Rajender Reddy, Patricia A. Sheiner, Velimir A. Luketic, Consuelo Soldevila-Pico, Michael W. Fried, Dona...> ;Liver Transplantation. 2006 Jan 1
• 137 citations
  Safety and immunogenicity of a nicotine conjugate vaccine in current smokers.
  Dorothy K. Hatsukami, Stephen I. Rennard, Douglas E. Jorenby, Mph Michael Fiore Md, Joseph S. Koopmeiners, Arjen de Vos, Gary Horwith, Paul R. Pentel> ;Clinical Pharmacology and Therapeutics. 2005 Nov 1
• 70 citations
  Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients.
  Ali Fattom, Steve Fuller, Myra Propst, Scott Winston, Larry R. Muenz, David Y. He, Robert B. Naso, Gary Horwith> ;Vaccine. 2004 Dec 16
• 28 citations
  Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines.
  John B. Robbins, Rachel Schneerson, Gary Horwith, Robert B. Naso, Ali Fattom> ;American Heart Journal. 2004 Apr 1
• 121 citations
  Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials.
  Ali Fattom, Gary Horwith, Steve Fuller, Myra Propst, Robert B. Naso> ;Vaccine. 2004 Feb 17
• 341 citations
  Use of a Staphylococcus aureus Conjugate Vaccine in Patients Receiving Hemodialysis
  Henry R. Shinefield, Steven Black, Ali Fattom, Gary Horwith, Scott A. Rasgon, Juan D. Ordonez, Hock Yeoh, David Law, John B. Robbins, Rachel Schneerson, Larry Muenz, S...> ;The New England Journal of Medicine. 2002 Feb 14
• 75 citations
  Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony.
  Shyam Sundar, N. Agrawal, Prabhat R. Sinha, Gary S. Horwith, Henry W. Murray> ;Annals of Internal Medicine. 1997 Jul 15
• A rapid immunofluorescent procedure for serodiagnosis of Q fever in mice, guinea pigs, sheep, and humans.
  Ascher, M. S., Horwith, G. S., Thornton, M. F., Greenwood, J. R., Berman, M. A.> ;Diagn Immunol. 1983
• Current use and future directions of adenovirus vaccine.
  Gurwith, M. J., Horwith, G. S., Impellizzeri, C. A., Davis, A. R., Lubeck, M. D., Hung, P. P.> ;Semin Respir Infect. 1989 Dec
• Join now to see all